- Home
- Publications
- Publication Search
- Publication Details
Title
Endoglin for Targeted Cancer Treatment
Authors
Keywords
Endoglin, CD105, TRC105, Angiogenesis, Vascular endothelial growth factor resistance, Antibody–drug conjugate, Hypoxia, Bone morphogenic protein, Transforming growth factor β, Antibody, Radioimmunoconjugate, Renal cell cancer, Sarcoma, Glioblastoma, Prostate cancer, Hepatocellular cancer
Journal
Current Oncology Reports
Volume 16, Issue 2, Pages -
Publisher
Springer Nature
Online
2014-01-20
DOI
10.1007/s11912-013-0365-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract A2: Exploratory textural CT evaluation of the combination of TRC105 (anti-endoglin monoclonal antibody; MAb) and bevacizumab (BEV) indicates partial response by Choi criteria in BEV refractory advanced cancer patients (pts) and identifies candidate markers of response.
- (2014) R. L. Korn et al. MOLECULAR CANCER THERAPEUTICS
- Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer
- (2013) F Joulain et al. BRITISH JOURNAL OF CANCER
- Inhibition of c-Met Reduces Lymphatic Metastasis in RIP-Tag2 Transgenic Mice
- (2013) B. Sennino et al. CANCER RESEARCH
- Endoglin for tumor imaging and targeted cancer therapy
- (2013) Madelon Paauwe et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination
- (2013) Charlotte Anderberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours
- (2012) Raquel Muñoz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
- (2012) L. S. Rosen et al. CLINICAL CANCER RESEARCH
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
- (2012) Olivier Nolan-Stevaux et al. PLoS One
- The VHL/HIF axis in clear cell renal carcinoma
- (2012) Chuan Shen et al. SEMINARS IN CANCER BIOLOGY
- Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
- (2011) Hao Hong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis
- (2011) William Dubinski et al. HUMAN PATHOLOGY
- Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
- (2011) Roselyne Castonguay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
- (2011) Petra Gromova et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Benign Mesenchymal Stromal Cells in Human Sarcomas
- (2010) A. Morozov et al. CLINICAL CANCER RESEARCH
- Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm
- (2010) Brigitte Royer-Pokora et al. HUMAN MOLECULAR GENETICS
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
- (2010) Sara I. Cunha et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma
- (2010) E Pardali et al. ONCOGENE
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Pathways mediating VEGF-independent tumor angiogenesis
- (2009) Napoleone Ferrara CYTOKINE & GROWTH FACTOR REVIEWS
- Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
- (2009) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature
- (2009) Shima Uneda et al. INTERNATIONAL JOURNAL OF CANCER
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
- (2008) R. S. Svatek et al. CLINICAL CANCER RESEARCH
- Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
- (2008) N. A. Dallas et al. CLINICAL CANCER RESEARCH
- Identification of a tumor-initiating stem cell population in human renal carcinomas
- (2008) Benedetta Bussolati et al. FASEB JOURNAL
- Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice
- (2008) Masanori Tsujie et al. INTERNATIONAL JOURNAL OF CANCER
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now